| Literature DB >> 28784593 |
Belén Rubio Ballester1, Jens Nirme1, Irene Camacho2, Esther Duarte2, Susana Rodríguez3, Ampar Cuxart3, Armin Duff1, Paul F M J Verschure1,4,5.
Abstract
BACKGROUND: Most stroke survivors continue to experience motor impairments even after hospital discharge. Virtual reality-based techniques have shown potential for rehabilitative training of these motor impairments. Here we assess the impact of at-home VR-based motor training on functional motor recovery, corticospinal excitability and cortical reorganization.Entities:
Keywords: computer applications software; hemiparesis; movement disorder; physical therapy; recovery of function, neuroplasticity; stroke; transcranial magnetic stimulation
Year: 2017 PMID: 28784593 PMCID: PMC5565792 DOI: 10.2196/games.6773
Source DB: PubMed Journal: JMIR Serious Games Impact factor: 4.143
Participants’ demographics and scores from clinical scales at baseline.
| Demographics | RGS (n=17) | Control (n=18) | |
| Gender (female), n (%) | 9 (53) | 12 (67) | .59a |
| Age, mean (SD) | 65.05 (10.33) | 61.75 (12.94) | .44b |
| Affected side (left), n (%) | 11 (65) | 9 (50) | .58a |
| Type (hemorrhagic), n (%) | 6 (33) | 6 (33) | .81a |
| Oxford class (LACc/PACd/TACe) | 4/3/4 | 6/2/4 | .65a |
| Days after stroke, mean (SD) | 1073.43 (767.74) | 798.06 (421.80) | .64b |
| MMSE [ | 28.24 (2.33) | 28.22 (2.34) | .08b |
| Hamilton [ | 3.71 (3.35) | 4.56 (3.24) | .40b |
| Grip force, mean (SD) | 6.15 (5.04) | 5.94 (5.85) | .69b |
| MRCf proximal [ | 3.47 (0.51) | 3.39 (0.61) | .76b |
| MRC distal [ | 2.82 (1.19) | 3.17 (0.99) | .44b |
| FMA [ | 42.94 (14.37) | 43.44 (13.48) | .89b |
| CAHAIg [ | 52.82 (23.10) | 53.50 (22.51) | .95b |
| Barthel [ | 89.53 (9.43) | 84.72 (14.19) | .48b |
| Ashworth proximal [ | 1.24 (1.25) | 1.22 (1.31) | .97b |
| Ashworth distal [ | 1.47 (1.51) | 1.00 (1.41) | .42b |
| VASh shoulder [ | 1.59 (2.76) | 2.61 (2.64) | .13b |
aChi-square test.
bWilcoxon rank-sum test.
cLAC: Lacunar stroke.
dPAC: Partial anterior circulation stroke.
eTAC: Total anterior circulation stroke.
fMRC: Medical Research Council.
gCAHAI: Chedoke Arm and Hand Activity Inventory (version CAHAI-13).
hVAS: Visual Analog Scale.
Figure 1Experimental setup and protocol: (A) Movements of the user’s upper limbs are captured and mapped onto an avatar displayed on a screen in first person perspective so that the user sees the movements of the virtual upper extremities. A pair of data gloves equipped with bend sensors captures finger flexion. (B) The Spheroids is divided into three subtasks: hit, grasp, and place. A white separator line divides the workspace in a paretic and non-paretic zone only allowing for ipsilateral movements.(C) The experimental protocol. Evaluation periods (Eval.) indicate clinical evaluations using standard clinical scales and Navigated Brain Stimulation procedures (NBS). These evaluations took place before the first session (W0), after the last session of the treatment (day 15, W3), and at follow-up (week 12, W12).
Figure 2Navigated Brain Stimulation (NBS) procedure. Bottom right: axial and coronal view of a magnetic resonance imaging (MRI) scan at the level of the stroke for one of the participants in the experimental group showing a partial anterior circulation infarct due to an embolism. Bottom right: Example of NBS mapped cortical motor representations; colored areas indicate the targeted cortical sites.
Effects of RGS treatment versus control on clinical scales within and between groups for the post treatment assessment at week 3 and the long-term follow up at week 12.
| Assessment | RGS (n=17) | Control (n=18) | Between Groups | Effect size | ||||||
| Improvement, mean (SD) | Improvement, mean (SD) | Cohen | ||||||||
| End (Week 3) | ||||||||||
| UE-FMa | 0.35 (1.62) | .43 | 1.22 (3.84) | .15 | .33 | −0.30 | ||||
| CAHAIb | 1.53 (2.4) | .01 | −0.67 (6.01) | .90 | .05 | 0.48 | ||||
| Barthel | 0.00 (1.87) | >.99 | 1.00 (2.87) | .25 | .44 | −0.41 | ||||
| MRCpc | 0.06 (0.24) | >.99 | 0.11 (0.32) | .50 | .61 | −0.17 | ||||
| MRCdd | 0.06 (0.43) | >.99 | 0.11 (0.47) | .63 | .74 | −0.12 | ||||
| Aspe | 0.00 (0.35) | >.99 | 0.06 (0.24) | >.99 | .32 | 0.40 | ||||
| Asdf | 0.12 (0.33) | .50 | 0.00 (0.34) | >.99 | .32 | 0.36 | ||||
| Grip force | 0.41 (1.78) | .89 | 0.38 (2.65) | .47 | .57 | 0.01 | ||||
| Hamilton | 0.88 (2.45) | .16 | 0.67 (1.57) | .13 | .66 | 0.10 | ||||
| VAS-Sg | 0.41 (1.81) | .05 | −0.28 (1.90) | .69 | .63 | 0.37 | ||||
| Follow-up (Week 12) | ||||||||||
| UE-FM | −0.18 (3.50) | .82 | 1.39 (3.63) | .11 | .21 | 0.34 | ||||
| CAHAI | −0.06 (6.51) | .74 | 0.44 (5.46) | .67 | .61 | −0.08 | ||||
| Barthel | −3.30 (8.09) | .29 | −0.11 (3.98) | .92 | .74 | −0.50 | ||||
| MRCp | −0.12 (0.78) | >.99 | 0.28 (0.46) | .06 | .06 | −0.62 | ||||
| MRCd | 0.29 (0.77) | .25 | 0.17 (0.62) | 45 | .98 | −0.17 | ||||
| Asp | 0.06 (0.65) | >.99 | 0.00 (0.34) | >.99 | >.99 | −0.12 | ||||
| Asdf | 0.29 (0.59) | .13 | 0.00 (0.00) | >.99 | .03 | 0.70 | ||||
| Grip force | 0.21 (1.45) | .73 | 0.23 (3.02) | .92 | .93 | −0.01 | ||||
| Hamilton | 0.35 (2.34) | .70 | 1.11 (3.53) | .42 | .93 | −0.25 | ||||
| VAS-S | 0.12 (2.06) | .92 | 0.78 (3.08) | .38 | .27 | −0.25 | ||||
aUE-FM: The upper extremity Fugl-Meyer Assessment.
bCAHAI: Chedoke Arm and Hand Activity Inventory (version CAHAI-13).
cMRCp: Medical Research Council for proximal muscles.
dMRCd: Medical Research Council for distal muscles.
eAsp: Ashworth Scale for proximal muscles.
fAsd: Ashworth Scale for distal muscles.
gVAS-S: Visual Analog Scale for Shoulder Pain.
Figure 3A: AEMF captures an improvement in finger flexion during treatment. Averaged movement profile of fingers excursion performed by one subject during one of the sessions. Units of finger flexion are expressed as a ratio of complete flexion. B: Mean changes in maximal finger flexion for all subjects in the RGS group across the three weeks of intervention, for both non-paretic (NPL) and paretic limbs (PL).
Figure 4Effects of domiciliary rehabilitation therapy on corticospinal efficacy. (A) Change in mean Stimulation Efficacy for extensor-carpi radialis (ECR) in the damaged hemisphere (pathological) and the intact hemisphere (non-pathological). (B) Change in mean Stimulation Efficacy for abductor pollicis brevis (APB). (C) Centroid displacements after therapy along anterioposterior and mediolateral axis. (D) Correlation of absolute centroid displacements after therapy with improvement in CAHAI score after therapy.